Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Carl Zeiss Meditec AG (AFXG.DE)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-02-28	140.85	-	No Rating
2022-03-15	136.35	170.00	Buy
2022-11-28	130.95	154.00	Buy
2022-12-14	126.90	156.00	Buy
2023-02-13	133.05	162.00	Buy
2023-04-25	123.35	148.00	Buy
2023-08-16	91.92	101.00	Neutral
2023-10-19	78.04	87.00	Neutral
2023-12-07	86.10	89.00	Neutral
2024-01-08	99.16	125.00	Buy
2024-02-13	110.15	130.00	Buy
2024-05-16	96.85	125.00	Buy
2024-06-24	66.80	71.00	Neutral
2024-10-29	62.90	65.00	Neutral
2025-01-08	46.52	50.00	Neutral
2025-02-17	55.10	55.00	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.